|
1
|
Travis WD, Brambilla E, Burke AP, Marx A
and Nicholson AG: World Health Organization classification of
tumours of the lung, pleura, thymus and heart. 4th ed. IARC Press;
Lyon, France: pp. 162015
|
|
2
|
Travis WD, Brambilla E, Nicholson AG,
Yatabe Y, Austin JHM, Beasley MB, Chirieac LR, Dacic S, Duhig E,
Flieder DB, et al: The 2015 World Health Organization
Classification of Lung Tumors: Impact of Genetic, Clinical and
Radiologic Advances Since the 2004 Classification. J Thorac Oncol.
10:1243–1260. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen M, Yang Q, Xu Z, Luo B, Li F, Yu Y
and Sun J: Survival analysis and prediction model for pulmonary
sarcomatoid carcinoma based on SEER database. Front Oncol.
11:6308852021. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Weissferdt A, Kalhor N, Correa AM and
Moran CA: ‘Sarcomatoid’ carcinomas of the lung: A
clinicopathological study of 86 cases with a new perspective on
tumor classification. Hum Pathol. 63:14–26. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sun L, Dai J, Chen Y, Duan L, He W, Chen
Q, Wang H, Zhu Y, Zhang H, Jiang G and Zhang P: Pulmonary
sarcomatoid carcinoma: experience from SEER database and Shanghai
Pulmonary Hospital. Ann Thorac Surg. 110:406–413. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rittmeyer A, Barlesi F, Waterkamp D, Park
K, Ciardiello F, von Pawel J, Gadgeel SM, Hida T, Kowalski DM, Dols
MC, et al: Atezolizumab versus docetaxel in patients with
previously treated non-small-cell lung cancer (OAK): A phase 3,
open-label, multicentre randomised controlled trial. Lancet.
389:255–265. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yang Z, Chen Y, Wang Y, Hu M, Qian F,
Zhang Y, Zhang B, Zhang W and Han B: Pembrolizumab plus
chemotherapy versus chemotherapy monotherapy as a first-line
treatment in elderly patients (≥75 Years Old) with non-small-cell
lung cancer. Front Immunol. 13:8075752022. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ma Y, Li W, Li Z, Chen J, Wang H, Jiang T
and Zhu J: Immunophenotyping of pulmonary sarcomatoid carcinoma.
Front Immunol. 13:9767392022. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jiao Y, Liu M, Luo N, Guo H and Li J:
Successful treatment of advanced pulmonary sarcomatoid carcinoma
with the PD-1 inhibitor toripalimab: A case report. Oral Oncol.
112:1049922021. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Matsumoto Y, Miura T, Horiuchi H and Usui
K: The Successful treatment of pulmonary pleomorphic carcinoma with
pembrolizumab: A case report. Case Rep Oncol. 10:752–757. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cimpeanu E, Ahmed J, Zafar W, DeMarinis A,
Bardarov SS, Salman S and Bloomfield D: Pembrolizumab-emerging
treatment of pulmonary sarcomatoid carcinoma: A case report. World
J Clin Cases. 8:97–102. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang J, Chai S, Wang R, Zheng G, Zhang K,
Huo B, Huo X, Jiang Y, Ji Z, Jiang P and Peng R: Expert consensus
on computed tomography-assisted three-dimensional-printed coplanar
template guidance for interstitial permanent radioactive I seed
implantation therapy. J Cancer Res Ther. 15:1430–1434. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Di X, Zhang H, Liu X, Zhao J, Gao Z, Yu H,
Su X, Liang Y and Wang J: A new technique for trans-perirectal
iodine-125 seed implantation in prostatic cancer guided by CT and
3D printed template: Two case reports. Front Oncol. 12:10319702022.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen E, Wang J, Zhang H, Zhang Y, Jia C,
Min X and Liang Y: Analysis of the efficacy and safety of
iodine-125 seeds implantation in the treatment of patients with
inoperable early-stage non-small cell lung cancer. J Contemp
Brachytherapy. 13:347–357. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liang Y, Di X, Liu Z, Zhao J, Wang Z, Zhao
J, Sui A, Zhang H and Wang J: 125I seeds implantation
for an elderly patient of skin squamous cell carcinomas with ulcer
guided by ultrasound. J Cancer Res Ther. 14:1660–1664. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gao Z, Yu H, Di X, Zhao J, Liang Y, Liu Z,
Wang J and Zhang H: Case report: 125I seed implantation
for rare malignant solitary fibrous tumor in the pelvic cavity: A
case report. Front Oncol. 12:8844912022. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang Y, Liu Z, Liang Y, Chen E, Zhang H,
Gao Z and Wang J: The effectiveness and prognostic factors of
radioactive iodine-125 seed implantation for the treatment of
cervical lymph node recurrence of esophageal squamous cell
carcinoma after external beam radiation therapy. J Contemp
Brachytherapy. 12:579–585. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gao Z, Zhang H, Zhang L, Yu H, Di X, Wang
Z, Liu Z, Sui A, Wang J and Shi G: 3D-Printed Template-Guided
125I Seed Brachytherapy: A salvage approach for
locoregional refractory recurrence of papillary thyroid cancer. Eur
Thyroid J. 10:504–510. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang H, Peng R, Li X, Wang Y, Jiang Y, Ji
Z, Guo F, Tian S, Sun H, Fan J and Wang J: The dosimetry evaluation
of 3D printing non-coplanar template-assisted CT-guided 125I seed
stereotactic ablation brachytherapy for pelvic recurrent rectal
cancer after external beam radiotherapy. J Radiat Res. 62:473–482.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang L, Zhang M, Pan X, Zhao M, Huang L,
Hu X, Wang X, Qiao L, Guo Q, Xu W, et al: Integrative serum
metabolic fingerprints based multi-modal platforms for lung
adenocarcinoma early detection and pulmonary nodule classification.
Adv Sci (Weinh). 9:e22037862022. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Issani A: An updated narrative review on
the management of the most common oncological and hematological
emergencies. Dis Mon. 69:1013552023. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yin X, Yang J, Zhang M, Wang X, Xu W,
Price CH, Huang L, Liu W, Su H, Wang W, et al: Serum metabolic
fingerprints on bowl-shaped submicroreactor chip for chemotherapy
monitoring. ACS Nano. 16:2852–2865. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Arshad AM, Pandiyan APS, Ayub II,
Chockalingam C and Thangaswamy D: Endovascular stenting for
malignant superior vena cava syndrome-Case series and review of
literature. Lung India. 40:165–168. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cozzi S, Augugliaro M, Ciammella P, Botti
A, Trojani V, Najafi M, Blandino G, Ruggieri MP, Giaccherini L, Alì
E, et al: The role of interstitial brachytherapy for breast cancer
treatment: An overview of indications, applications, and technical
notes. Cancers (Basel). 14:25642022. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li X, Zhou H, Mou K, Zheng Y, Li H, Ren P,
Ye H, Lin S, Pang H, Wu J and Xiang L: Risk factors for operation
complications of high dose rate 3-dimensional interstitial
brachytherapy for lung cancer. Clin Lung Cancer. 24:e187–e194.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang Q, Huang W, Hsu JC, Song L, Sun X, Li
C, Cai W and Kang L: CD146-targeted nuclear medicine imaging in
cancer: State of the art. View (Beijing). 4:202200852023.PubMed/NCBI
|
